Late Chronic Phase Chronic Myelogenous Leukemia

Summary

Late Chronic Phase Chronic Myelogenous Leukemia is a clinical trial^[1].

Key Facts

• Late Chronic Phase Chronic Myelogenous Leukemia is in the country of United States^[2].
• Late Chronic Phase Chronic Myelogenous Leukemia's instance of is recorded as clinical trial^[3].
• Late Chronic Phase Chronic Myelogenous Leukemia's start time is recorded as +2001-07-31T00:00:00Z^[4].
• Late Chronic Phase Chronic Myelogenous Leukemia's end time is recorded as +2006-12-31T00:00:00Z^[5].
• Late Chronic Phase Chronic Myelogenous Leukemia's sponsor is recorded as The University of Texas MD Anderson Cancer Center^[6].
• Late Chronic Phase Chronic Myelogenous Leukemia's main subject is recorded as leukemia^[7].
• Late Chronic Phase Chronic Myelogenous Leukemia's number of participants is recorded as {'unit': '1', 'amount': '+47'}^[8].
• Late Chronic Phase Chronic Myelogenous Leukemia's title is recorded as Therapy of Late Chronic Phase Chronic Myelogenous Leukemia (CML) With High-Dose Gleevec (STI571)^[9].
• Late Chronic Phase Chronic Myelogenous Leukemia's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+15'}^[10].
• Late Chronic Phase Chronic Myelogenous Leukemia's ClinicalTrials.gov ID is recorded as NCT01092741^[11].
• Late Chronic Phase Chronic Myelogenous Leukemia's research intervention is recorded as imatinib mesylate^[12].
• Late Chronic Phase Chronic Myelogenous Leukemia's clinical trial phase is recorded as phase II clinical trial^[13].
• Late Chronic Phase Chronic Myelogenous Leukemia's research site is recorded as University of Texas at Houston Police Department^[14].
• Late Chronic Phase Chronic Myelogenous Leukemia's research subject recruitment status is recorded as completed^[15].
• Late Chronic Phase Chronic Myelogenous Leukemia's study type is recorded as interventional study^[16].